Lakefront Biotherapeutics

LKFT

----

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Lakefront Biotherapeutics(LKFT) predict that the Revenue is 7.427 M (-90.85%), Miss estimate;the EBIT is -73 M (+57.51%), Beat estimate;the EPS is 0.252 (+110%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.01B90.85%

0.03B58.54%

-0.03B32.31%

EBITExceed expectations

-0.07B57.51%

-0.11B35.91%

+0.04B21.60%

EPSExceed expectations

0.2521110.00%

-1.497440.63%

+1.749569.37%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD